These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17240851)

  • 1. [Stereotyped behaviors and compulsive complaints of pain improved by fluvoxamine in two cases of frontotemporal dementia].
    Ishikawa H; Shimomura T; Shimizu T
    Seishin Shinkeigaku Zasshi; 2006; 108(10):1029-35. PubMed ID: 17240851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frontotemporal dementia: treatment response to serotonin selective reuptake inhibitors.
    Swartz JR; Miller BL; Lesser IM; Darby AL
    J Clin Psychiatry; 1997 May; 58(5):212-6. PubMed ID: 9184615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluvoxamine for stereotypic behavior in patients with dementia.
    Trappler B; Vinuela LM
    Ann Pharmacother; 1997 May; 31(5):578-81. PubMed ID: 9161652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of fluvoxamine as a treatment for behavioral symptoms in frontotemporal lobar degeneration patients.
    Ikeda M; Shigenobu K; Fukuhara R; Hokoishi K; Maki N; Nebu A; Komori K; Tanabe H
    Dement Geriatr Cogn Disord; 2004; 17(3):117-21. PubMed ID: 14739531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compulsive behaviors as presenting symptoms of frontotemporal dementia.
    Mendez MF; Perryman KM; Miller BL; Swartz JR; Cummings JL
    J Geriatr Psychiatry Neurol; 1997 Oct; 10(4):154-7. PubMed ID: 9453681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obsessive and compulsive symptoms in schizophrenia: a randomized controlled trial with fluvoxamine and neuroleptics.
    Reznik I; Sirota P
    J Clin Psychopharmacol; 2000 Aug; 20(4):410-6. PubMed ID: 10917401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clomipramine in the treatment of compulsive behavior in frontotemporal dementia: a case series.
    Furlan JC; Henri-Bhargava A; Freedman M
    Alzheimer Dis Assoc Disord; 2014; 28(1):95-8. PubMed ID: 22892646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluvoxamine in the treatment of obsessive-compulsive disorder and related conditions.
    Goodman WK; Ward H; Kablinger A; Murphy T
    J Clin Psychiatry; 1997; 58 Suppl 5():32-49. PubMed ID: 9184625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluvoxamine. An updated review of its use in the management of adults with anxiety disorders.
    Figgitt DP; McClellan KJ
    Drugs; 2000 Oct; 60(4):925-54. PubMed ID: 11085201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of central poststroke pain with the selective serotonin reuptake inhibitor fluvoxamine.
    Shimodozono M; Kawahira K; Kamishita T; Ogata A; Tohgo S; Tanaka N
    Int J Neurosci; 2002 Oct; 112(10):1173-81. PubMed ID: 12587520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized controlled trial of Japanese patients with obsessive-compulsive disorder--effectiveness of behavior therapy and fluvoxamine.
    Nakatani E; Nakagawa A; Nakao T; Yoshizato C; Nabeyama M; Kudo A; Isomura K; Kato N; Yoshioka K; Kawamoto M
    Psychother Psychosom; 2005; 74(5):269-76. PubMed ID: 16088264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disinhibition as a side effect of treatment with fluvoxamine in pediatric patients with obsessive-compulsive disorder.
    Harris E; Eng HY; Kowatch R; Delgado SV; Saldaña SN
    J Child Adolesc Psychopharmacol; 2010 Aug; 20(4):347-53. PubMed ID: 20807074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined fluvoxamine and extended-release methylphenidate improved treatment response compared to fluvoxamine alone in patients with treatment-refractory obsessive-compulsive disorder: A randomized double-blind, placebo-controlled study.
    Zheng H; Jia F; Han H; Wang S; Guo G; Quan D; Li G; Huang H
    Eur Neuropsychopharmacol; 2019 Mar; 29(3):397-404. PubMed ID: 30595354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complex compulsive behaviour in the temporal variant of frontotemporal dementia.
    Rosso SM; Roks G; Stevens M; de Koning I; Tanghe HLJ ; Kamphorst W; Ravid R; Niermeijer MF; van Swieten JC
    J Neurol; 2001 Nov; 248(11):965-70. PubMed ID: 11757960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluvoxamine in the treatment of compulsive buying.
    Black DW; Monahan P; Gabel J
    J Clin Psychiatry; 1997 Apr; 58(4):159-63. PubMed ID: 9164426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Two cases of adult Down syndrome treated with selective serotonin re-uptake inhibitor for behavior disorders].
    Hirayama T; Kobayashi T; Fujita T; Fujino O
    No To Hattatsu; 2004 Sep; 36(5):391-4. PubMed ID: 15461027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of obsessive-compulsive disorder with fluvoxamine: a multicentre, double-blind, placebo-controlled trial.
    Goodman WK; Kozak MJ; Liebowitz M; White KL
    Int Clin Psychopharmacol; 1996 Mar; 11(1):21-9. PubMed ID: 8732310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolactin response to d-fenfluramine in obsessive-compulsive patients, and outcome of fluvoxamine treatment.
    Monteleone P; Catapano F; Di Martino S; Ferraro C; Maj M
    Br J Psychiatry; 1997 Jun; 170():554-7. PubMed ID: 9330023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological stealing in dementia: poor response to SSRI medications.
    Mendez MF
    J Clin Psychiatry; 2011 Mar; 72(3):418-9. PubMed ID: 21450164
    [No Abstract]   [Full Text] [Related]  

  • 20. Effective treatment with low-dose fluvoxamine for obsessive-compulsive disorder after neurosurgery: a case report.
    Kunitake Y; Hurukawa Y; Yamada S
    Clin Neuropharmacol; 2009; 32(6):344-5. PubMed ID: 19952875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.